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ABSTRACT
Introduction: Dengue fever can be graded into dengue fever (DF), dengue hemorrhagic fever (DHF) and
dengue shock syndrome (DSS). The CD8+ T lymphocytes mediate antiviral activity by producing cytokines
and directly destroyed the dengue virus infected cells. This study focuses in observing the kinetics of CD8+ T
lymphocytes absolute and relative count in dengue patients.
Objectives: To observe the kinetics of CD8+ T lymphocytes absolute and relative count in dengue patients.
Methods: The research design used is a descriptive study. This research measures and observes the kinetics
CD8+ T lymphocytes absolute and relative count from day 2 to day 7. The CD8+ T lymphocytes count was
determined using flowcytometry. Data was analyzed using ANOVA and independent t test with p<0.05
considered as significant.
Results:The CD8+ T lymphocytes absolute count is low during the beginning of disease course and it gradually
increases from day 2 to day 7. The CD8+ T lymphocytes relative count decreases from day 2 to day 3, and
start to increase back from day 3 to day 7. There is no difference between the level of CD8+ T lymphocytes
absolute count and relative count between DF and DHF patients.
Conclusion: There is an increase in CD8+ T lymphocytes absolute count and relative count in dengue patients.
There is no difference between DF and DHF patients in CD8+ T lymphocytes absolute and relative count.
Keywords: dengue fever; dengue hemorrhagic fever; CD8+ T lymphocytes; absolute count; relative count.
INTISARI
Pendahuluan: Demam Dengue dapat digolongkan menjadi Demam Dengue (Dengue Fever/DF), Demam
Berdarah Dengue (Dengue Hemorragic Fever/DHF) dan Sindrom Syok Dengue (Dengue Shock Syndrome/DSS).
Limfosit T CD8+ T memediasi aktivitas antiviral dengan menghasilkan sitokin-sitokin dan menghancurkan sel
yang terinfeksi virus dengue secara langsung. Penelitian ini mempelajari perubahan-perubahan yang terjadi
pada jumlah limfosit T CD8+ pada pasien dengue.
Tujuan: Mempelajari kinetika limfosit T CD8+ yaitu hitung absolut dan relatif pada pasien-pasien Dengue.
Methods: Desain penelitian ini adalah penelitian deskriptif. Pada penelitian ini, diukur dan diamati kinetika
limfosit T CD8+ yaitu jumlah absolut dan relatif pada hari ke 2 sampai hari ke 7. Hitung limfosit T CD8+
ditentukan dengan flowsitometry. Data dianalisis dengan Uji ANOVA dan Uji t dengan batas signifikan p<0,05.
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Hasil: Hitung absolut limfosit T CD8+ rendah pada permulaan perjalanan penyakit tetapi secara bertahap
meningkat dari hari ke 2 sampai hari ke 7. Hitung relatif limfosit T CD8+ T menurun dari hari ke 2 sampai hari
ke 3 dan meningkat kembali dari hari ke 3 sampai hari ke 7. Tidak terdapat perbedaan antara hitung absolut
dan relatif limfosit T CD8+ antara pasien-pasien DF dan DHF.
Simpulan: Terdapat peningkatan hitung absolut dan relatif limfosit T CD8+. Tidak terdapat perbedaan antara
hitung absolut dan relatif limfosit T CD8+ antara pasien-pasien DF dan DHF.
Kata Kunci: demam dengue; demam berdarah dengue; Limfosit T CD8+; hitung absolut; hitung
relatif
INTRODUCTION
Dengue viruses are mosquito-borne,
transmitted through infected female Aedes
mosquito, causing dengue. Dengue viruses,
belonging to family of Flaviviridae , are
positive-strand RNA viruses. There are four
subtypes of dengue virus, which are DENV-1,
2, 3 and 4, each composing of similar antigen.
As such, life-long immunity acquired after
being infected by one of the dengue virus
does not serves immunity as well for the
remaining dengue viruses1.
Dengue virus is covered by a lipid bilayer
with 2 proteins designated as envelope (E) and
membrane-associated (M) proteins. The E
protein is the protein involved in immune
system, whereby it functions by binding to
cellular receptors, then fuses with cell
membrane. Neutralizing antibodies produced
from immune system will recognize the epitopes
in the E protein, thus induce the immunity
against dengue viruses. The exact mechanism is
still under investigation2.
The dengue viruses are transmitted by
female Aedes mosquito. The incubation period
of dengue viruses is 4.5-7 days, rarely exceeding
10 days3. Infected individuals will only show sign
and symptoms of dengue infection after this
period. The sign and symptoms that appeared
last for 3-10 days. Infected individuals are
contagious and prone to spread the virus to the
mosquitoes when the blood contains high load
of viruses, period that starts slightly before the
sign and symptoms appear, which lasts for 5
days4. These mosquitoes that transmit diseases,
known as vectors, carry the dengue virus
throughout the life after biting an infecting5. The
virus in the mosquito will be further incubated
for 8-12 days in its body before it is virulent to
individuals who are bitten4.
Currently, dengue is estimated to have
infected 2.5 billion people, circulating in endemic
area and periodically caused widespread
epidemics. Dengue is endemic in nearly 100
countries, consisting of Asia, Pacific, America,
Africa and Caribbean. Estimation has been made
that there are new incidence of dengue infection,
50-100 millions occurred yearly, ended with
22,000 deaths due to dengue infection6.
Situated in Asia, Indonesia has high
prevalence of dengue cases, with the number
of cases increasing yearly. In 1998, Indonesia
recorded 72,133 cases of dengue fever (DF) and
dengue hemorrhagic fever (DHF). During that
year, dengue occurs in 56 countries which in total
more than 1.2 million cases reported to WHO6.
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According to report from Regional Office of
South East Asia, Thailand has the highest
number of cases until 2003. From 2004 onwards,
Indonesia took over as the highest and the trend
of cases increases rapidly, with Indonesia alone
achieve 57% of cases in 20067.
From 1 January to 30 April 2004, according
to WHO, 58,301 cases of dengue infection was
reported to Indonesian Ministry of Health with
658 deaths due to dengue infection. The current
predominant affecting virus is DENV-3 (37%), as
compared to the remaining three dengue
viruses8. According to the 1993-1994 outbreak
reported in Papua, DENV-3 is the predominant
serotype. This is due to fact that this dengue
virus serotype is recognized in many cases of
DHF during the outbreak compare to other
strainsof viruses such as DENV-1 and DENV-29.
Among 30 affected provinces such as
Jakarta, Bali and East Nusa Tenggara, 17 of
provinces reported to have outbreaks of dengue
with unusually high numbers of cases8. In year
2007, WHO received reports that there were
150,000 of dengue cases, where 25,000 of these
cases are from Jakarta and West Java6.
The exact mechanism of pathogenesis of
dengue virus is still not clearly defined. Several
hypotheses have been proposed and the most
recent hypothesis is the serotype cross-reactive
T lymphocytes. In this theory, the CD8+ T
lymphocytes secrete cytokines that alter the
endothelial cells and cause plasma leakage,
resulting in dengue hemorrhagic fever (DHF) and
dengue shock syndrome (DSS). The cytokines also
play an important role in lysing dengue viruses-
infected monocyte10.
The CD8+ T lymphocytes play a major role
againts viruses. The body produced CD8+ T
lymphocytes in order to fight against viruses.
Produced by the body in response to viral
antigen, CD8+ T lymphocytes aims to kill the
infected cells and prevent further spread of viral
infection. Asides from CD8+ T lymphocytes, CD4+
T lymphocytes also play a critical role in immune
system of the body in dengue infection. CD4+ T
lymphocytes are needed to generate CD8+ T
lymphocytes continuously and antibody. It also
secretes lymphokines, a substance that can
attract and activate macrophage and natural
killer (NK) cells. With these mechanisms, body
immune system can fight to protect against
dengue virus11. Previous research reported that
the level of soluble CD4 increases during viremia,
with soluble CD8 level increases soon after the
period. This indicates that CD4+ T cells are
activated during viremia and CD8+ T cells are
activated after CD4+ T cells are activated first12.
The CD8+ T lymphocytes also contribute
in protecting body during dengue virus
infection. CD8+ T lymphocytes mediate the
antiviral activity by producing cytokines such
as interferon-gamma and tumor necrosis
factor – alpha, besides direct killing the
infected cells 13. The lack of researches
regarding the role of CD8+ T lymphocytes in
dengue virus stress the need to further explore
the relationship between CD8+ T lymphocytes
and dengue viruses. This study focuses in
observing the kinetics of CD8+ T lymphocytes
in dengue patients and investigating the
correlation of the kinetics with dengue severity.
MATERIALS AND METHODS
This study is a descriptive study,
conducted in Dr. Sardjito Hospital from April
to May 2009. The study is done to observe
the kinetics of CD8+ T lymphocyte in dengue
patients. The subjects used in this study are
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patients aged above 14 years old with the
diagnosis of dengue fever using the WHO
criteria (1997), and are admitted in Dr. Sardjito
Hospital.
The inclusion criterias are patients admitted
in Dr. Sardjito Hospital, > 14 years old, diagnosed
to have dengue infection with NS-1 positive (+ve),
had fever in the first and second day and had
signed informed consent. The exclusion criterias
are patients who also suffered from other
diseases, other than dengue infection, or
dropped out due to loss of follow up and
contracted with fever not due to dengue
infection.
Using the vacutainer tubes with K3EDTA, 3
mL of venous blood is withdrawn from the
anterior cubiti vein. The blood withdrawn is
used as sample. The specimen used is stored in
room temperature and examined within 24
hours.
First, 50 µL of whole blood specimen
obtained from patient is inserted into a tube.
Next, 10 µL of Tritest reagent CD8 FITC-HLA-DR
and PE/CD45 are added into the tube. Then,
the specimen is mixed well with vortex mixer
and incubated in a dark room with room
temperature for 15 minutes. After that, 450 µL
of lysing solution is added into the tube. Lastly,
the specimen is mixed well and incubated in a
dark room at room temperature for 15 minutes
again. The CD8+ T lymphocytes absolute count
of the sample is measured using fluorescence
activated cell sorter (FACS).
Dengue is classified based on WHO criteria
(1997)14. The day patient admitted to hospital
for observation until the day being discharge
from hospital is recorded. CD8+ T lymphocytes
absolute count is the number of CD8+ T
lymphocytes present in blood. CD8+ T
lymphocytes relative count is the percentage of
CD8+ T lymphocytes out of the total population
of cells
With the data obtained, mean of absolute
count and relative count of CD8+ T lymphocytes
number for each day is calculated and presented
in graph. Data was analyzed using ANOVA and
independent t test. ANOVA is conducted to
determine the significance of the mean
differences between each day. Independent t-
test is performed to analyze the significance of
the mean differences between DF and DHF for
each day. If the result p<0.05, the mean
differences is significant. If the result p>0.05, the
mean differences is not significant.
RESULTS AND DISCUSSION
There were a total of 32 participants in this
study. From these 32 participants, only 28 are
included in this study since the data of 4
participants are incomplete. Among these 28
participants, there was equal distribution of
participants with 14 of them each suffered
dengue fever (DF) and dengue hemorrhagic fever
(DHF) respectively. For the DF participants, 9 of
them were male while 5 of them were female.
On the other hand, DHF participants consisted
of 8 males and 6 females.
The research focused on the condition of
participants from day 2 until day 7, measuring
the absolute count and relative count of CD8+
T lymphocytes. During data analysis, there
were some data that were not present. Hence,
the number of data obtained for each day
slightly differed. At the same time, as some of
the data were incomplete and had insufficient
numbers of data, day 1 and day 8 were excluded
from the data analysis. This was because
statistical analysis would not be valid if data of
day 1 and day 8 were included. In this study,
the data distribution were observed using
boxplot. If the data distribution were not
normally distributed, a transformation is
conducted to have a normal curve.
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Figure 1. Graph showing day to day mean of CD8+ T lymphocytes
absolute count from day 2 to day 7
A. CD8+ T lymphocytes absolute count
Figure 1 shows mean of absolute count of
CD8+ T lymphocytes which increased from day
2 until day 7 generally in both dengue fever (DF)
and dengue hemorrhagic fever (DHF) patients.
The normal range of absolute count of CD8+ T
lymphocytes used in this study is according to
MultiSET Software from United States of
America which is 190 cells/µL to 1140 cells/µL15.
In DF patients, the absolute count is low
from day 2, then it gradually increases until day
5 (mean 346.62cells/µl ± 288.80). After that,
there was a sharp increase from day 5 to day 6,
and continued to rise in day 7 (mean 872.37cells/
µl ± 317.07). As determined by ANOVA, there
was a statistically significant difference between
mean number of CD8+ T lymphocytes absolute
count (p-value =0.000). The CD8+ T lymphocytes
absolute count significantly increases in day 6
(658.25 cells/µl ± 382.651, p=0.021) and in day 7
(872.37 cells/µl ± 317.071, p=0.000) compared
to day 2.
On the other hand, in DHF patients, the
absolute count gradually increased from day
2 until day 5. Then, there was an abrupt rise
in day 6 (722.36cells/µl ± 408.78), but then it
declined slighty in day 7 (608.16cells/µl ±
140.88). There is a statistically significant
difference between mean of CD8+ T
lymphocytes absolute count (p = 0.000). The
decline in day 7 was not significant (p = 1.000).
Sarasombath et al. (1988) found out that
the absolute CD8+ cells in the study conducted
among 61 children aged 8 months to 12 years
decreased in the febrile stage.16 In fact, the
lowest amount of CD8+ cells absolute count
was recorded to be on the first day of
defeverscence. After that, the CD8+ cells rise
quickly and reached beyond the normal value
on the second day of defeverscence, follow
by gradual decrease of absolute count back
to normal range.
Study by Kurane et al. (1991) that measured
the soluble CD8 (sCD8) suggested that there was
no elevation of the level of sCD8 in the sera of
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Figure 2. Graph showing day to day mean of CD8+ T lymphocytes
relative count from day 2 to day 7
DF patents during days 1-2017. Their study also
found out that the levels of sCD8 were higher in
DHF patients on days 3-20 after onset of fever
in comparison to DF patients. DHF patients show
highest level of sCD8 in days 5-6.
Fadilah et al. in Malaysia recruited 109
patients with fever who were suscpected to
have DHF in 199918. They found out that the
absolute count of CD8 cells reduces in DHF
patients. CD8+ cells are low, differentiating
DHF from DF patients in the fever phase of
dengue viral infection.
In year 2006, Azeredo et al. has a study
which investigate 60 dengue patients in Brazil19.
This study shows that there is a decrease in
absolute CD8+ T cell counts in dengue patients
in comparison to controls. The level of CD8 was
reduced during acute phase.
B. CD8+ T lymphocytes relative count
Figure 3 shows the mean of CD8+ T
lympho-cytes relative count increased from
day 2 until day 7 generally in both dengue
fever and dengue hemorrhagic fever patients.
The normal range of CD8+ T lymphocytes
relative count used in this study is according
to MultiSET Software from United States of
America, which is 13% - 41%15.
In dengue fever, the relative count dropped
slightly from day 2 to day 3, then it steadily
increased from day 3 (29.95% ± 8.59) until day 7
(41.64% ± 7.44). As determined by ANOVA, there
was a statistically significant difference between
mean of CD8+ T lymphocytes relative count
(p=0.008). The mean relative count of CD8+ T
lymphocytes was statistically significantly higher
in day 7 (41.63% ± 7.24, p=0.038) compared to
day 2.
On the other hand, dengue hemorrhagic
fever patients’ relative count gradually increases
for each day from day 2 (mean 31.69% ± 7.74)
until day 7 (39.18% ± 8.32). ANOVA analysis
shows there was no statistically significant
difference between groups of mean of CD8+ T
lymphocytes relative count (p=0.105) in dengue
hemorrhagic fever.
In 2006, Mongkolsapaya et al. conducted
a research among children aged 8 to 10 years
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in Thailand, which aims to investigate T
lymphocytes responses in dengue viral
infection20. Their research results shows that
the frequency of CD8+ T lymphocytes rise to
low levels in acute phase, then peak in 2 weeks
during samples followed up.
According to Friberg et al. (2011) the level
of CD8+ T cells were high during acute phase
and also in the days shortly after the fever of
patients subsides, the period known as early
convalescence21. They also observed changes
in the CD8+ T lymphocytes in DF and DHF for
both primary and secondary infection of
dengue.
The research conducted by Mladinich et al.
shows that percentage of CD8 activation
increases and peak in day 1422. Mladnich et al.
also proposed that higher viral loads causes
higher level of T lymphocytes expansion, hence
causing increase in disease severity. Dung et al.
conducted a research in year 2010, with the
result showing the percentage of CD8+ T
lymphocytes were most prominent after
defervescence23.
C. Comparison of CD8+ T lymphocytes
between DF and DHF
Independent t-test was performed to
compare the CD8+ T lymphocytes absolute and
relative count between DF and DHF. The analysis
did not show any significant difference in any
days between DF and DHF in both absolute count
and relative count (p >0.05). These findings
indicate that the CD8+ T lymphocytes absolute
and relative count were not significantly related
with the severity of dengue virus infection.
Previously reported by Kurane et al. (1991),
the activation of T lymphocytes is greater in DHF
than in DF, with significant correlation between
severity of disease and increase level of sCD817.
This research suggests that high levels of T cell
activation may be related to the pathogenesis
of DHF.
This is supported by research conducted in
Thailand by Green et al., whereby the level of
sCD8 were significantly higher in children with
DHF compared to those with DF24. The difference
in the findings may be due to the fact that both
the researches were conducted among children
in Thailand. On the other hand, this study is
performed in Yogyakarta among adults.
Research by Mongkolsapaya et al. showed
that the magnitude T cell responses were related
to disease severity20. Their research in year 2006
clearly showed significantly higher level of T cell
responses in DHF patients in comparison with
patients who had DF and normal group patients.
The results of this research have led to a theory
of T cell response involving in dengue
pathogenesis. This may be due to the
contribution of activated T lymphocytes to
severe plasma leakage. Entrance of virus into
monocytes and macrophages causes viral
peptides to be presented on cell surface. These
antigen-presenting cells interacted with memory
T lymphocytes and induce proliferation and
production of proinflammatory cytokines,
including TNF-alpha and IFN-gamma. These
cytokines directly affect vascular endothelial
cells and causes plasma leakage. Hence, it is
predicted that DHF patients would have higher
level of T lymphocytes activation25.
Simmons et al. in 2005 found out that the
magnitude of T cell responses were not
significantly related with disease severity26.
Analyzing Vietnamese adults, their research
result showed that there was no association
between T cell response and dengue severity.
However, there are several limitations in this
study. This study only involved a limited number
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of participants. The duration of the study is also
limited to a week, whereby no follow up is
conducted.
CONCLUSION
The CD8+ T lymphocytes absolute count is
low during the beginning of disease course and
it gradually increases from day 2 to day 7. The
CD8+ T lymphocytes relative count decreases
from day 2 to day 3, and start to increase back
from day 3 to day 7. There is no difference
between the level of CD8+ T lymphocytes
absolute count and relative count between DF
and DHF.
SUGGESTION
The result of the study would be more
accurate if there are more participants involved
in the study, with wider range in age. The
outcome would be more favorable as well if the
duration of the study, which is from day 2 until
day 7 can be lengthened to obtain more
accurate result.
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